PHERGain and PHERGain-2 advance therapeutic de-escalation in early HER2-positive breast cancer in selected patients

B Results from the PHERGain study confirm that the combination of two targeted agents allows one third of patients to be treated without chemotherapy and…
posteditor
posteditor
Articles: 21727

Other News